Hepatitis C Virus (HCV) Clinical Trials
3 recruiting trials for Hepatitis C Virus (HCV). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Hepatitis C Virus (HCV) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of California, Los Angeles (1), AbbVie (1), McGill University Health Centre/Research Institute of the McGill University Health Centre (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Mobile Enhanced Prevention Support (MEPS) (behavioral, 1 trial), followed by Control, NIATx.
Track Hepatitis C Virus (HCV) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
California MEPS Hub
The California Hub for HIV/SUD Prevention Research with Reentry Populations addresses the question: "Can the evidence-based MEPS intervention be adapted and implemented at a range...
Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
The objective of this study is to assess the safety, tolerability and effectiveness of 8-week Glecaprevir/Pibrentasvir (G/P) in participants taking either prescribed or illicit...
Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Hepatitis C Virus (HCV), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Hepatitis C Virus (HCV), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Hepatitis C Virus (HCV), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.